CYTOCHROMA

cytochroma-logo

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

#People #Financial #Website #More

CYTOCHROMA

Social Links:

Industry:
Biotechnology Clinical Trials Pharmaceutical

Founded:
1996-01-01

Address:
Kingston, Ontario, Canada

Country:
Canada

Website Url:
http://www.cytochroma.com

Total Employee:
51+

Status:
Closed

Contact:
847-236-7707

Total Funding:
75.83 M USD

Technology used in webpage:
SPF Amazon GoDaddy DNS AWS Global Accelerator AppRiver



Current Advisors List

seiichi-kiso_image

Seiichi Kiso Board of Director @ Cytochroma
Board_member
2008-07-30

joseph-regan_image

Joseph Regan Member of the Board of Directors @ Cytochroma
Board_member
2004-01-01

Acquisitions List

Date Company Article Price
2006-06-29 Proventiv Therapeutics Proventiv Therapeutics acquired by Cytochroma N/A

Investors List

caisse-de-depot-et-placement-du-quebec_image

Caisse de Depot et Placement du Quebec

Caisse de Depot et Placement du Quebec investment in Series C - Cytochroma

canadian-medical-discoveries-fund_image

Canadian Medical Discoveries Fund

Canadian Medical Discoveries Fund investment in Series C - Cytochroma

mitsubishi-tanabe-pharma_image

Mitsubishi Tanabe Pharma

Mitsubishi Tanabe Pharma investment in Series C - Cytochroma

venturelink-lp_image

VentureLink LP

VentureLink LP investment in Series C - Cytochroma

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series C - Cytochroma

vengrowth-asset-management_image

VenGrowth Asset Management

VenGrowth Asset Management investment in Series C - Cytochroma

bdc-capital-corporation_image

BDC Capital Corporation

BDC Capital Corporation investment in Series C - Cytochroma

growthworks_image

GrowthWorks Capital

GrowthWorks Capital investment in Series C - Cytochroma

genechem_image

GeneChem

GeneChem investment in Series C - Cytochroma

vengrowth-asset-management_image

VenGrowth Asset Management

VenGrowth Asset Management investment in Series C - Cytochroma

Official Site Inspections

http://www.cytochroma.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Cytochroma"

Cytochroma - Crunchbase Company Profile & Funding

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin โ€ฆSee details»

Cytochroma - Crunchbase Company Profile & Funding

Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochromaโ€™s automated โ€ฆSee details»

Cytochroma Company Profile 2024: Valuation, Funding โ€ฆ

Cytochroma was founded in 2017. Where is Cytochroma headquartered? Cytochroma is headquartered in Roslin, United Kingdom. What is the size of โ€ฆSee details»

Cytochroma - The Org

Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .See details»

Cytochroma Inc.: Contact Details and Business Profile

Cytochroma is a development stage pharmaceutical company with three products currently in clinical development. We specialize in identifying and developing novel vitamin D hormone โ€ฆSee details»

Cytochroma - Company Profile - Tracxn

Nov 27, 2024 Cytochroma - Developer of human tissue models for research purposes and drug discovery. Raised funding over 1 round from 3 investors. Valued at $2.85M. Founded by Kate โ€ฆSee details»

Cytochroma - LinkedIn

Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature ...See details»

Cytochroma - Overview, News & Similar companies | ZoomInfo.com

Dec 15, 2021 Who is Cytochroma. Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent โ€ฆSee details»

Cytochroma - Company Profile - Tracxn

Dec 1, 2024 Cytochroma - Developer of therapeutics to treat secondary hyperparathyroidism (SHPT). Raised a total funding of $74M over 7 rounds from 11 investors. Founded by Kate โ€ฆSee details»

Cytochroma Inc. - Markham, Canada - bionity.com

May 27, 2010 Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical โ€ฆSee details»

Cytochroma - Products, Competitors, Financials, Employees, โ€ฆ

Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D โ€ฆSee details»

Cytochroma - Ownership and Business Overview - Mergr

Mar 4, 2013 Cytochroma was founded in 1996. Medical Products M&A Summary in 2013. Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2013. The โ€ฆSee details»

Cytochroma Inc. | BDC.ca

Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin โ€ฆSee details»

Cytochroma (Drug Discovery) - PitchBook

Jan 13, 2010 Cytochroma (Drug Discovery) was acquired on 01-Jun-2020. Who acquired Cytochroma (Drug Discovery)? Cytochroma (Drug Discovery) was acquired by OPKO Health. โ€ฆSee details»

Cytochroma - Contacts, Employees, Board Members, Advisors

Organization. Cytochroma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 1. Number of Board Member and Advisor โ€ฆSee details»

Cytochroma Inc. | Scientist.com

Cytochroma Inc. 5295 John Lucas Drive Burlington, ON, L7L 6A8 Canada: Get started If your organization has a Scientist.com marketplace, you can log in here to order products and โ€ฆSee details»

Cytochroma - Contacts, Employees, Board Members, Advisors

Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .See details»

Cytochromes - Examples, Definition, Types, Structure, Function

Jun 28, 2024 Cytochromes are complex compounds essential to the energy-producing processes in cells. These proteins, found within the cellโ€™s powerhouses called mitochondria, โ€ฆSee details»

Cytochroma - Funding, Financials, Valuation & Investors

Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs . Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much โ€ฆSee details»

linkstock.net © 2022. All rights reserved